LMP polymorphisms do not influence disease expression in psoriatic arthritis

Clinical and Experimental Rheumatology

Volumn 14, Issue 6, 1996, Pages 661-664

  Hohler T ^a,b   Schneider, P M ^b   Rittner, C ^b   Hasenclever, P ^c   Meyer Zum Buschenfelde K H ^a   Marker Hermann E ^a  

^a I Medical Department

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Karl Aschoff Klinik   (Germany)

Author keywords

disease expression; LMP polymorphisms; psoriatic arthritis

Indexed keywords

LOW MOLECULAR WEIGHT PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, PSORIATIC; CYSTEINE ENDOPEPTIDASES; DISEASE PROGRESSION; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0030471285     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. GLADMAN D: Natural history of psoriatic arthritis. Baillières Clin Rheumatol 1994; 8: 379-94.
2. EASTMOND CJ: Genetics and HLA antigens. Baillières Clin Rheumatol 1994; 8: 263-76.
3. REVEILLE JD, CONANT MA, DUVIC M: Human immuno-deficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum 1990; 33: 1574-8.
4. BIJLMAKERS MJ, PLOEGH HL: Putting together an MHC class I molecule, Curr Opin Immunol 1993; 5: 21-6.
5. CERUNDULO V, KELLY A, ELLIOT T, TROWSDALE J, TOWNSEND A: Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol 1995; 25: 554-62.
6. MAKSYMOWYCH WP, WESSLER A, SCHMITT-EGENOLF M, SUAREZ-ALMAZOR M, TITZEL G, VON BORSTEL RC, PAZDERKA F, RUSSELL AS: Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 1994; 21: 665-9.
7. MAKSYMOWYCH WP, SUAREZ-ALMAZOR M, CHOU CT, RUSSELL AS: Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis 1995; 54: 321-4.
8. BURNEY RO, PILE KD, GIBSON K, CALIN A, KENNEDY LG, SINNOTT PJ, POWIS SH, WORDSWORTH BP: Analysis of the MHC class II encoded components of the class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 58-60.
9. TERASAKI PI, PARK MS: Microdroplet lymphocyte cytotoxicity test. In: RAY, HARE, PEDERSEN, MULLALLY (Eds.): Manual of Tissue Typing Techniques. OHEW Publication No. (NIH) 76-545, 1986, pp 69-80.
10. BEIN G, GLÄSER R, KIRCHNER H: Rapid HLA-DRB1 geno-typing by nested PCR amplification. Tissue Antigens 1992; 39: 68-73.
11. DENG GY, MUIR A, MACLAREN NK, SHE JX: Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 1995; 56: 528-34.
12. HAYASHI K: PCR-SSCP: a simple and sensitive method for detection of mutations in genomic DNA. PCR Methods and Applications 1991; 1: 34-8.
13. SPINARDI L, MAZARS R, THEILLET C: Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res 1991; 19: 4009.
14. SAMMONS DW, ADAMS LD, NISHIZAWE EE: Ultrasensitive silver-based color staining of polypeptides in polyacrylamide gels. Electrophoresis 1981; 2: 135-41.
15. CAMPBELL DR, TROWSDALE J: Map of the human histocompatibility complex. Immunol Today 1993; 14: 349-52.
16. AARON SL, MILLER M, HOWARD J: Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis and peripheral arthitis. J Rheumatol 1985; 12: 897-904.